Darunavir Vincristine 981

Prezcobix label

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 2
Clinical Effects

Potential for increased risk of vincristine adverse effects

Management

Consider temporarily withholding cobicistat-containing ARV regimen in patients who develop significant hematologic or gastrointestinal adverse effects. If ARV regimen must be withheld for a prolonged period of time, initate a revised regimen

Import ID
981